ICICI Direct Suggested Top 3 Logistics & Pharma Stocks To Buy, Check Target Price

Indian stock markets are mostly flat this week, Sensex closed at 61,872.99 points and Nifty closed at 18,403.40 points. However, ICICI Direct suggested these 3 chemical, logistics and pharma stocks to buy for high returns.

Neogen Chemical

The current market price of Neogen Chemical is Rs. 1,365/ share. Its share price has surged by 420.89% in the last 5 years, but surged only by 2.51% in the last 1 year. "In our chemical coverage, we like Neogen Chemical. Trigger for Neogen Chemical's future revenue growth would be increasing CRAMS opportunity. Buy with a target price of Rs. 1645," ICICI Direct mentioned.

Mahindra Logistics

The current market price of Mahindra Logistics is Rs. 1,365/ share. Its share price has surged by 22.07% in the last 5 years, but fell by 34.53% in the last 1 year. According to ICICI Direct, "We remain positive on Mahindra Logistics. Mahindra Logistics is an end to end 3PL logistics solution provider, from performing milk run to in-factory logistics, warehousing to first mile and last mile logistics. Continued momentum in the non-auto segment of MLL to drive higher contribution from the value added services and thereby improve its margins as well as opportunity to capture higher wallet share of existing customers."

Sun Pharma

The current market price of Sun Pharma is Rs. 1,014.50/ share. Its share price has surged by 96.19% in the last 5 years, and gained by 27.06% in the last 1 year. "In healthcare coverage we like Sun Pharma. Higher contribution from specialty and strong domestic franchise is likely to change the product mix towards more remunerative business. Buy with a target price of Rs. 1225," the brokerage firm said.

Disclaimer

The above stocks were picked from the brokerage report by ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.